We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AcelRX Pharmaceuticals Inc | NASDAQ:ACRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.86 | 0.861 | 0.89 | 0 | 01:00:00 |
Delaware
|
001-35068
|
41-2193603
|
||
(State of incorporation)
|
(Commission File No.)
|
(IRS Employer Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
ACRX
|
The Nasdaq Global Market
|
Item 5.03.
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
Exhibit
No. |
Description
|
|
3.1
|
||
3.2
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Date: October 25, 2022
|
||
ACELRX PHARMACEUTICALS, INC.
|
||
By:
|
/s/ Raffi Asadorian
|
|
Name:
|
Raffi Asadorian
|
|
Title:
|
Chief Financial Officer
|
1 Year AcelRX Pharmaceuticals Chart |
1 Month AcelRX Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions